CRTO 250117 47.50P (CRTO250117P47500) Stock Options, News & Quotes

5.30
0.000.00%

15min DelayTrading Sep 4 14:05 ET

0.00High0.00Low

SymbolStock Name

PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry

WatchlistPaper Trade

Comments

Iwill TradeScared

Jul 23 00:45

$Criteo (CRTO.US)$ Support and Resistance Levels
Support Level@$39.83, established through clear consolidation after the last breakout.
Resistance Level@ 52-week High at $45, representing a significant psychological barrier for investors. These levels are instrumental in identifying potential entry and exit points for trades, highlighting areas of buyer and seller equilibrium.

Moomoo AI

Mar 17 07:58

Despite strong share performance, the market may not be judging the company on earnings growth due to decreased earnings per share. Revenue and earnings trends could have influenced share price. The gain surpassed the average annual return of 7% over five years, suggesting the company may be attracting new investors.

Optimism for Criteo (NASDAQ:CRTO) Has Grown This Past Week, Despite Five-year Decline in Earnings

Moomoo AI

Mar 1 17:41

Petrus Advisers views Criteo as an 'attractive investment opportunity' that could be strengthened by requested actions. Ocular Therapeutix's leadership changes are seen as a positive step towards becoming a leader in retina care. Starboard previously labeled Fortrea shares as 'undervalued' and an 'attractive investment opportunity'.

Criteo, Ocular Therapeutix, and More Stocks See Action From Activist Investors -- Barrons.com

Moomoo AI

Feb 28 13:53

The CEO & Director's recent share selling, even at below current price, may indicate insiders see the shares as fully valued. Despite significant insider ownership, the long-term outlook lacks positivity.

Don't Ignore The Insider Selling In Criteo

Moomoo AI

Feb 22 10:25

Petrus Advisers urges Criteo for a strategic review and an investor day to explain the Retail Media strategy and a new mid-term plan, believing the current stock fluctuation is not rewarding.

Criteo Gains as Activist Pushes for Strategic Review, Board Refresh